Sebo, Chary .
HRN: 15-10-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2023
CEFUROXIME 500MG (TAB)
02/12/2023
02/18/2023
ORAL
500 Mg
BID
S/P NSVD, MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes